Work

Safety and tolerability of AZD2171, a highly potent VEGFR inhibitor, in patients with advanced prostate adenocarcinoma

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.3049

Authors: C. Ryan, W. M. Stadler, B. J. Roth, T. A. Puchalski, M. Koehler, E. J. Small

Institutions: University of California, San Francisco, Vanderbilt University, University of Chicago

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W50056423

Cites:

Cited by: 4

Related to: 10